• Login
    View Item 
    •   Vlerick Repository Home
    • Research Output
    • Research Reports
    • View Item
    •   Vlerick Repository Home
    • Research Output
    • Research Reports
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of Vlerick RepositoryCommunities & CollectionsPublication DateAuthorsTitlesSubjectsKnowledge Domain/IndustryThis CollectionPublication DateAuthorsTitlesSubjectsKnowledge Domain/Industry

    My Account

    LoginRegister

    Contact & Info

    ContactVlerick Journal ListOpen AccessVlerick Business School

    Statistics

    Display statistics

    The consequences of greater net price transparency for innovative medicines in Europe: Searching for a consensus

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Thumbnail
    Name:
    Van_Dyck_W_RR_Consequences of ...
    Size:
    1.114Mb
    Format:
    PDF
    Description:
    Main article
    Download
    Author
    Riccaboni, Massimo
    Van Dyck, Walter
    Gyger, Pius
    Bentata, Pierre
    Marques-Gomes, Joao
    Czech, Marcin
    Mestre-Ferrandiz, Jorge
    Greiner, Wolfgang
    Voncina, Luka
    Groot, Wim
    Wilsdon, Tim
    Ross-Stewart, Kirsty
    Pistollato, Michele
    Show allShow less
    Publication Year
    2020
    Publication Number of pages
    62
    
    Metadata
    Show full item record
    Abstract
    The merits of greater or lesser net price transparency (NPT) has been a topic for discussion for many years across business and industry in general. However, in the past few years, the debate on NPT of innovative medicines has intensified, with organisations such as the United Nations (UN), the World Health Organization (WHO) and the Organisation for Economic Co-operation and Development (OECD) leading calls for greater transparency in the pharmaceutical sector, specifically focused on prices. In May 2019 the World Health Assembly (WHA) approved a resolution to support the greater public disclosure of prices and research and development (R&D) costs for both medicines and other health products supported by several European and non-European governments. To contribute to the international debate on the transparency of medicine prices in Europe, Merck Sharp & Dohme (MSD) asked Charles River Associates (CRA) to curate a panel of experts to develop evidence on the impact of greater NPT of innovative medicines. Professor Walter Van Dyck1 and Professor Massimo Riccaboni2 were asked by CRA to lead this research, supported by a wider panel of 10 experts from a range of European markets. A structured literature review was first conducted to summarise the theoretical consequences of greater NPT. This was supplemented with a survey of national payers and payer experts3 from a range of European markets. This was used as pre-read information for an expert advisory board of 12 economic and health economic experts representing 12 countries selected to give a range of market sizes, national income and payer approaches. The debate and the consensus reached by the advisory board have been summarised in this report. In addition, a computational model has been developed by two key investigators to provide new, empirical evidence to illustrate the impact of NPT on different European markets.
    Keyword
    Net Price Transparency (NPT)
    Knowledge Domain/Industry
    Operations & Supply Chain Management
    Special Industries : Healthcare Management
    DOI
    10.13140/RG.2.2.27978.80320/1
    URI
    http://hdl.handle.net/20.500.12127/6616
    Other links
    https://www.researchgate.net/publication/347356137_The_consequences_of_greater_Net_Price_Transparency_for_innovative_medicines_in_Europe_Searching_for_a_consensus
    ae974a485f413a2113503eed53cd6c53
    10.13140/RG.2.2.27978.80320/1
    Scopus Count
    Collections
    Research Reports

    entitlement

     
    DSpace software (copyright © 2002 - 2023)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.